Dr. Vincent Patrick Devlin Jr., DO, MHS

Dr. Devlin practices at Eisenhower Health in Rancho Mirage, California, part of Eisenhower Medical Center.

Dr. Devlin's NPI, 1871910752, was assigned on March 27, 2014. Dr. Devlin graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 2014. Dr. Devlin holds California license 20A16972.

Dr. Devlin's primary practice is Eisenhower Health, at 39-000 Bob Hope Drive, Rancho Mirage, CA 92270 in Riverside County. The practice phone is (760) 340-3911. Dr. Devlin also practices at Eisenhower Medical Center, 39000 Bob Hope Dr, Rancho Mirage, CA 92270.

Dr. Devlin's primary practice is Eisenhower Health in Rancho Mirage, California, part of Eisenhower Medical Center. The medical group on file is Eisenhower Health. Dmand AI also links Dr. Devlin to 1 more breast imaging center, 1 clinical lab and 1 dialysis center, each named with a free account. Dr. Devlin's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Devlin practices, 4 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Devlin's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Devlin is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dr. Devlin is licensed in California.

Dmand AI lists acute sinusitis, asthma, chronic nasal allergies, hives, immune deficiency disease and upper respiratory infection (URI) among the conditions Dr. Devlin treats.

CMS data shows 17,750 Medicare services from Dr. Devlin across 10 procedure codes in 2024, for 778 Medicare patients. Medicare paid $145,339 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 778 Medicare patients who saw Dr. Devlin in 2024. The largest group is 65 to 74, with 368 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Devlin's median patient age at 73, with 60% women.

In 2024, Dr. Devlin wrote 4,847 Medicare Part D claims for 749 patients. 81% of them were for generic drugs. CMS names the drug for 4,718 of them, across 39 drugs with 11 or more claims each, at $759,417 in total drug cost. In 2023, CMS named 2,855 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Devlin for performance year 2024, reported as part of a group. Dr. Devlin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Devlin, published from 2010 to 2017. Dr. Devlin's most frequent co-authors are Victoria Ritsa Dimitriades, MD, Jack B. Basil, MD and Stephanie V. Blank, MD.

CMS Open Payments shows 95 general payments to Dr. Devlin from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 75% of the total. Sanofi and Genzyme US Companies paid the most, $1,659.

Dr. Devlin graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 2014.

Dr. Devlin is in network with 15 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.